NIC5-15

VA Office of Research and Development · Phase 2 active Small molecule

At a glance

Generic name	NIC5-15
Also known as	d-Pinitol
Sponsor	VA Office of Research and Development
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Development of NIC5-15 in the Treatment of Alzheimer's Disease (PHASE2)
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NIC5-15 CI brief — competitive landscape report
NIC5-15 updates RSS · CI watch RSS
VA Office of Research and Development portfolio CI